← Leaderboards
Eugene Bozymski
University Of North Carolina Chapel Hill
$1,559,955
Attributed
$1,559,955
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,559,955 · 1
By mechanism
M01$1,559,955 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Douglas A Drossman$8,090,089
- Christine J Moe$3,825,642
- Kim L Isaacs$2,243,938
- William E Whitehead$15,555,686
- Mark J Kutcher$3,795,959
Others in their field
Top investigators on “Antiulcer Drug”
- Mark J Kutcher · University Of North Carolina Chapel Hill$1,559,955
- George Sachs · University Of California Los Angeles$1,399,244
- Dennis M Jensen · University Of California Los Angeles$829,064
- Kim L Isaacs · University Of North Carolina Chapel Hill$676,290
- Joseph R Pisegna · University Of California Los Angeles$416,435
- Christopher E Forsmark · University Of Florida$245,672
Research focus
Antiulcer DrugBismuthCitratesClarithromycinClinical ResearchCombination ChemotherapyDrug Screening /EvaluationGastrointestinal Disorder ChemotherapyGastrointestinal InfectionHelicobacterHuman SubjectHuman Therapy EvaluationOmeprazoleOral AdministrationRanitidine
Grant awards (7)
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$190,747
M01 · FY2002 · RR
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$294,555
M01 · FY2001 · RR
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$190,747
M01 · FY2001 · RR
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$294,555
M01 · FY2000 · RR
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$294,555
M01 · FY2000 · RR
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$294,555
M01 · FY2000 · RR
HELICOBACTER PYLORI ORAL GR122311X W/ CLARITHROMYCIN$241
M01 · FY2000 · RR